AI-powered media bias analysis by Daily Composite
Based on analysis of recent Stat News articles using Claude, GPT-4o, Gemini, and Grok. Scores reflect framing and presentation, not factual accuracy.
Learn about our methodology →According to Daily Composite AI analysis of recent Stat News articles, the outlet scores pending — placing it in the Unrated category.
This rating is generated by four independent AI models (Claude, GPT-4o, Gemini, and Grok) analyzing word choice, framing, sources cited, and emotional language in recent articles. The consensus score reduces single-model bias.
At the hearing, the judge heard from mothers who lost sons to overdose, a teenager born into withdrawal, and people who spent years dealing with addiction treatment.
J. Craig Venter, the scientist whose relentless ambition helped turn genetics from an artisanal trade into an industrialized information machine, died at 79.
Katherine Szarama, who joined the FDA last year to serve as Vinay Prasad’s deputy, will now fill his shoes at CBER.
Examining the past statements and writings of Trump's third surgeon general nominee, Dr. Nicole Saphier, on vaccines, autism, peptides, diet and more.
Why are investors excited about hair loss drugs? Will AI make clinical trials run more smoothly? And more in "The Readout LOUD," STAT's weekly biotech podcast.
On Thursday, researchers published in Science the results of a study that tested an OpenAI model on diagnostic and clinical reasoning tasks.
Trump slammed Sen. Bill Cassidy for blocking his surgeon general pick, as he nominated a replacement.
FDA moves to remove semaglutide, tirzepatide, and liraglutide from its 503B compounding list, saying there's no shortage of GLP-1 drugs from Novo Nordisk and Eli Lilly.
A 'quintuple agonist,' Alector halts it Alzheimer's trial, and more biotech news from The Readout
Elevance said a top exec would depart, days after the Justice Department asked to depose him.
In this edition of STAT Health Tech: FDA's plan to use AI to speed up trials, Hinge's new migraine device, and boosting cancer screening with texts.
ACA membership is tumbling after Congress failed to extend extra subsidies that helped people afford the coverage.
